Probiotic Senior to maintain immunity and protect against viruses

• Respiratory system protection
  Proven effectiveness of the Bl-04 strain to protect the respiratory tract from ARVI.
• Increased immune response
  Targeted probiotics to maintain natural immune defense in adulthood.
• Regular bowel function
  Improvement of intestinal peristalsis to prevent and prevent constipation.
• Suitable for vegetarians
  DR capsules of plant origin with delayed release for aiming action in the intestine.

Active longevity
Support the health of the older generation!
More than 70% of the cells of the immune system are located in the digestive tract, so our intestines are the first line of defense against potentially harmful pathogens and are closely related to the general state of health. Environmental pollution, allergies, respiratory infections and the increasing prevalence of colds and flu reduce natural immune defense.
A special age group of the population subject to impaired composition of the intestinal microbiota is the older generation. Unfortunately, immune function, as well as the level of bifidobacteria, decreases with age. The motor function of the intestine also decreases, which complicates the processes of detoxification of the body and provokes constipation.
Taking the Senior probiotic complex helps to restore digestive balance and support immune functions in adulthood.
Strengthen your immunity and enjoy every moment!

A new generation of probiotics

Especially to maintain intestinal microflora in adulthood
Monostams of bifidobacterium bifidobacterium lactis HN019™ (HOWARU® BIFIDO) and Bifidobacterium lactis Bl-04® are aimed at restoring the balance of intestinal microflora, supporting immune function, protecting against infections and acute respiratory viral infections in adulthood, as well as regulating intestinal peristalsis and preventing constipation.

• Bifidobacterium lactis Bl-04®
  Studies of the Bl-04® strain confirm the effectiveness of its use to strengthen immunity. How does it work? After the virus gets on the mucous membranes of the respiratory tract, it begins to multiply in the cells. The immune system responds to the attack of the virus, and the body activates its defenses, directing them to fight the pathogen. The probiotic strain Bl-04® can help break the reproduction cycle of the virus that causes ARVI. It has been proven that taking Bl-04® reduces the amount of rhinovirus in the nasal mucosa¹.
  Bifidobacterium lactis Bl-04®:
  • slows down or stops the development of respiratory diseases at the initial stage;
  • supports the immune system of the nasopharynx;
  • helps maintain respiratory health in healthy and active people.
• Bifidobacterium lactis HN019™
  The probiotic properties of B. lactis HN019™ are well studied and described in more than 100 scientific publications. It has been demonstrated that it tolerates an acidic environment and survives when passing through the human intestine. The data indicate that HN019™ can affect colon peristalsis and also modulates immune function by enhancing cellular immune activity in the elderly².
  A study published in the journal Nutrient showed that daily consumption of Bifidobacterium lactis HN019™ enhances the function of special cells of the immune system - killer lymphocytes (NK cells). The data show that the strain B. lactis HN019™ was highly effective in increasing phagocytic capacity and moderately effective in increasing the tumoricidal activity of NK cells, which is important in old age to prevent the development of degeneration of body cells.
  Interestingly, B. lactis HN019™ also supports normal intestinal physiological function in adults, including those with reduced immune defense, competes and excludes potential pathogens.
  In addition, B. lactis HN019™ reduces the time of intestinal transit and increases the frequency of defecation in functional constipation (possibly due to the modulation of the "intestine - brain - microbiota" axis). Thus, B. lactis HN019™ is a probiotic that can help alleviate disorders associated with intestinal motility disorders³.

Premium probiotics from the world market leader - IFF (under the HOWARU® brand)
• High stability
The viability of strains throughout the shelf life.
• Acid resistance
Resistance of strains to gastric and bile acids.
• Absolute security
Tested for toxicity and completely safe for humans.
• Genetic safety screening
Tested for virulence, toxicogenic properties and lack of potential for transmission of antibiotic resistance.
• Proven effectiveness
A large amount of world-class clinical studies.
• Full identification of strains
The genome of each strain is completely sequenced and deciphered.

Synbiotic is more than a probiotic!
Nutrition Senior from Siberian Wellness is a synbiotic complex. In addition to strains of lactobacilli, the product is based on fructooligosaccharides (FOS) - prebiotics, a type of water-soluble fiber.
Consisting of short fructose chains FOS:
- not absorbed by the body;
- do not affect the blood sugar level;
- serve as a source of nutrition for probiotic bacteria;
- help to suppress toxic bacteria in the intestines.

For whom?
• Age 45+.
• All adults as a prevention of acute respiratory viral infections during viruses and colds.
• People with immunodeficiency conditions.

• 2 monostams
Bifidobacterium animalis subsp. lactis HN019™ (HOWARU® BIFIDO) and Bifidobacterium animalis subsp. lactis Bl-04® are part of normal intestinal microflora.
• 7x109 CFE of bifidobacteria
Effective dosage with clinically proven action.
• 1 capsule per day
Only two weeks to achieve a preventive result.

¹ Supplements with probiotics for symptoms of respiratory diseases.
West NP, et al. Clin Nutr 2014;33(4):581-587.
https://pubmed.ncbi.nlm.nih.gov/24268677/
² Effect of the HN019™ strain on the function of cellular immunity in healthy elderly people: systematic review and meta-analysis.
Miller LE, Lehtoranta L, Lehtinen MJ. Nutrients. 2017;9:191.
https://pubmed.ncbi.nlm.nih.gov/28245559/
³ Effect on intestinal health of Bifidobacterium lactis HN019.
Jing Cheng, Arja Laitila. Front Nutr. 2021.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712437/